SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/92806299658E36B0843E27123AD8E91EED030960B0485A19775C0D0EC7DA4198E939D29E049A3F6FE14B565B790D7806>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/92806299658E36B0843E27123AD8E91EED030960B0485A19775C0D0EC7DA4198E939D29E049A3F6FE14B565B790D7806
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/92806299658E36B0843E27123AD8E91EED030960B0485A19775C0D0EC7DA4198E939D29E049A3F6FE14B565B790D7806
http://www.w3.org/2000/01/rdf-schema#comment
"patients with the CC genotype for rs12459419 have a substantial response to Gemtuzumab Ozogamicin making this a potential biomarker for the selection of patients with a likelihood of significant response to Gemtuzumab Ozogamicin."
xsd:string
http://purl.uniprot.org/uniprot/#_DEFC87912698C4E05EF73E12123AC84B4843474151FF7EBCF0D45DF40296508CD94EFAA29ADD55AF24209C68FBEA3E59
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/92806299658E36B0843E27123AD8E91EED030960B0485A19775C0D0EC7DA4198E939D29E049A3F6FE14B565B790D7806
http://purl.uniprot.org/uniprot/Q546G0
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/92806299658E36B0843E27123AD8E91EED030960B0485A19775C0D0EC7DA4198E939D29E049A3F6FE14B565B790D7806
http://purl.uniprot.org/uniprot/#_Q546G0-mappedCitation-28644774
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/92806299658E36B0843E27123AD8E91EED030960B0485A19775C0D0EC7DA4198E939D29E049A3F6FE14B565B790D7806